RNU6-830P

Across TCGA pan-cancer cohorts, RNU6-830P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-830P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU6-830P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-830P expression acts as an unfavorable survival marker.

BRCA, LAML, and UCEC are the cancer types where RNU6-830P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	II,III,IV	0.336	0.913	<.001	66	view →
LAML	DFS	Tertile	All	0.167	0.575	.035	36	view →
UCEC	DFS	Tertile	All	0.168	0.838	<.001	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-830P–BRCA (OS)

Open the BRCA breakdown →